HoldingsChannel.com



Clearside Biomedical insider buying image
The table below summarizes the most recent Clearside Biomedical insider buying information, with links below the price to see the CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more information about why Clearside Biomedical insider buys are important for investors to follow.
DateInsiderPriceAmount
4-18-2024
Insider Buy
Anthony S. Gibney
$1.30
CAGR »
$129,664.50
100,000 shares
3-20-2024
Insider Buy
Ngai Hang Victor Chong
CHIEF MEDICAL OFFICER
$1.60
CAGR »
$48,000.00
30,000 shares
2-7-2024
Insider Buy
Bradford T. Whitmore
>10% Owner
$1.35
CAGR »
$599,999.40
444,444 shares
11-1-2023
Insider Buy
Bradford T. Whitmore
>10% Owner
$0.74
CAGR »
$99,849.15
135,778 shares
10-3-2023
Insider Buy
Nancy J. Hutson
Director
$0.86
CAGR »
$8,600.00
10,000 shares
9-25-2023
Insider Buy
Clay Thorp
Director
$0.86
CAGR »
$8,600.00
10,000 shares
11-17-2022
Insider Buy
Nancy J. Hutson
Director
$1.33
CAGR »
$39,900.00
30,000 shares
8-16-2021
Insider Buy
Nancy J. Hutson
Director
$5.68
CAGR »
$17,040.00
3,000 shares
1-6-2021
Insider Buy
Bradford T. Whitmore
>10% Owner
$2.85
CAGR »
$999,988.25
350,750 shares
12-24-2020
Insider Buy
Bradford T. Whitmore
>10% Owner
$1.95
CAGR »
$99,896.80
51,195 shares
11-16-2020
Insider Buy
Bradford T. Whitmore
>10% Owner
$1.69
CAGR »
$104,928.80
62,000 shares
8-18-2020
Insider Buy
William D. Humphries
Director
$1.78
CAGR »
$9,943.08
5,586 shares
8-13-2020
Insider Buy
Bradford T. Whitmore
>10% Owner
$1.63
CAGR »
$571,680.00
350,000 shares
11-12-2019
Insider Buy
Charles A. Deignan
Chief Financial Officer
$1.14
CAGR »
$8,550.00
7,500 shares
11-11-2019
Insider Buy
George M. Lasezkay
CEO
$1.16
CAGR »
$13,920.00
12,000 shares
3-15-2019
Insider Buy
Charles A. Deignan
Chief Financial Officer
$1.36
CAGR »
$13,600.00
10,000 shares
12-6-2018
Insider Buy
Clay Thorp
Director and >10% Owner
$1.36
CAGR »
$10,880.00
8,000 shares
6-4-2018
Insider Buy
Daniel H. White
President and CEO
$9.07
CAGR »
$99,770.00
11,000 shares
3-23-2018
Insider Buy
Charles A. Deignan
Chief Financial Officer
$11.79
CAGR »
$5,895.00
500 shares
3-22-2018
Insider Buy
Gerald D. Cagle
Director
$11.89
CAGR »
$89,175.00
7,500 shares
8-15-2017
Insider Buy
Christy L. Shaffer
Director
$7.00
CAGR »
$7,700.00
1,100 shares
8-11-2017
Insider Buy
Gerald D. Cagle
Director
$7.08
CAGR »
$35,400.00
5,000 shares
8-14-2017
Insider Buy
Charles A. Deignan
Chief Financial Officer
$7.07
CAGR »
$7,065.00
1,000 shares
5-22-2017
Insider Buy
Christy L. Shaffer
Director
$8.00
CAGR »
$8,800.00
1,100 shares
3-27-2017
Insider Buy
Gerald D. Cagle
Director
$7.10
CAGR »
$99,854.40
14,064 shares
3-20-2017
Insider Buy
Christy L. Shaffer
Director
$6.90
CAGR »
$15,180.00
2,200 shares
3-16-2017
Insider Buy
Gerald D. Cagle
Director
$6.84
CAGR »
$34,200.00
5,000 shares
6-7-2016
Insider Buy
Clay Thorp
Director and >10% Owner
$7.00
CAGR »
$5,499,998.00
785,714 shares
6-7-2016
Insider Buy
Hatteras Venture Advisors IV SBIC, LLC
>10% Owner
$7.00
CAGR »
$2,900,002.00
414,286 shares
6-7-2016
Insider Buy
Hatteras Venture Advisors III, LLC
>10% Owner
$7.00
CAGR »
$749,994.00
107,142 shares
6-7-2016
Insider Buy
Investments S.A.R.L. Rmi
>10% Owner
$7.00
CAGR »
$299,999.00
42,857 shares

Also See: Institutional Holders of CLSD
Also See: SEC filings

CLSD Performance Since Insider Purchase
Below we present the annualized performance delivered by Clearside Biomedical stock since 4-18-2024 (the date of the most recent insider purchase). The performance of the investment from the time Clearside Biomedical insider buying occurred is the ultimate test of whether insiders were right about CLSD being a good buy.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 04/19/2024
End date: 04/30/2024
Start price/share: $1.31
End price/share: $1.26
Dividends collected/share: $0.00
Total return: -3.82%
Annualized Gain: -126.65%
Starting investment: $10,000.00
Ending investment: $9,618.00
Years: 0.03

Clearside Biomedical Insider Buying

This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent Clearside Biomedical insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).

Also See: Funds Holding CLSD

Quotes delayed 20 minutes

Email EnvelopeFree CLSD Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Other companies seeing insider buying close in time to when the Clearside Biomedical Insider Buying occurred are:

BlackRock MuniYield Pennsylvania Quality Fund Insider Buying
Fastenal Insider Buying
Postal Realty Trust Insider Buying
UL Solutions Inc Class A Insider Buying
First Bancorp Inc (ME) Insider Buying
Angel Oak Financial Strategies Income Term Trust Insider Buying
CADIZ Insider Buying
Atlas Energy Solutions Inc (New) Insider Buying
Sunoco LP Insider Buying
Park National Corp (Newark OH) Insider Buying

Clearside Biomedical Insider Buying | www.HoldingsChannel.com

Copyright © 2013 - 2024, All Rights Reserved Nothing in Holdings Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact Holdings Channel; Meet Our Editorial Staff.